PRLD compared with SPRY: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

SPRYARS Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

SPRYARS Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only SPRY 18

—ALKunlistedsupplier

—ALK U.Sunlistedsupplier

—Recordati Irelandunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Aegis Therapeutics

unlistedsupplier

14 more · SPRY chain ›

PRLDPrelude Therapeutics Inc

3.89· pre 3.89· delayed

Mkt cap$309.6MRevenue$6MQ2 FY26Revenue—

SPRYARS Pharmaceuticals, Inc.

3.37· pre 3.40

Pre-marketSep 2 '83

Mkt cap$336.1MRevenue$34MQ2 FY26Revenue$84MFY25

Compare

Pre-marketSep 2 '83

PRLDPrelude Therapeutics Inc

SPRYARS Pharmaceuticals, Inc.

3.89pre 3.89delayed

Price

3.37pre 3.40

$309.6M

Mkt cap

$336.1M

Q2 FY26$6M

Revenue

$34MQ2 FY26

—

Revenue

$84MFY25

PRLD3.89vsSPRY3.37Pre-marketSep 2 '83